CTLA-4 blockade: unveiling immune regulation.
Dranoff
Glenn
G
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000276:immunology*; D015551:Autoimmunity; D060908:CTLA-4 Antigen; D019496:Cancer Vaccines / Q000276:immunology*; D006801:Humans; D008353:Mannitol / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D009829:Oleic Acids / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D019496:Cancer Vaccines; D009829:Oleic Acids; C477385:montanide ISA 51; D008353:Mannitol